NCT01091805View on ClinicalTrials.gov

Correlation of Oropharyngeal Pepsin and Gastroesophageal (GE) Reflux

CompletedOBSERVATIONAL
Enrollment

143

Participants

Timeline

Start Date

December 31, 2008

Primary Completion Date

September 30, 2013

Study Completion Date

October 31, 2013

Conditions
Gastroesophageal Reflux Disease (GERD)
Trial Locations (1)

27157

Wake Forest University Baptist Medical Center, Winston-Salem

Sponsors

Collaborators (1)

Takeda
All Listed Sponsors
collaborator

Takeda

INDUSTRY

lead

Wake Forest University Health Sciences

OTHER

NCT01091805 - Correlation of Oropharyngeal Pepsin and Gastroesophageal (GE) Reflux | Biotech Hunter | Biotech Hunter